Skip to main content
. 2018 Apr 20;38(7):1149–1179. doi: 10.1177/0271678X18771440

Table 4.

Review of the effect of anti-migraine drugs against SDs.

Anti-migraine drugs
Results
Drug Reference Species Type SD induction Dosage Number Amplitude Propagation Threshold Duration Frequency
Tonabersat Read et al.192 Cat In vivo KCl 3–10 mg/kg/day ip.
Tonabersat Smith et al.193 Cat In vivo KCl 3–10 mg/kg/day ip.
Tonabersat Bradley et al.194 Cat In vivo KCl 10 mg/kg/day ip.
Tonabersat Read et al.192 Rat In vivo KCl 10 mg/kg/day ip.
Topiramate Akerman and Goadsby195 Cat, rat In vivo Mechanical 30 mg/kg/day iv. =
Topiramate Unekawa et al.196 Rat In vivo KCl 50, 100, 200, or 600 mg/kg ip.
Topiramate Ayata et al.50 Rat In vivo Electrical, KCl 40–80 mg/kg/day = =
Topiramate Tozzi et al.197 Rat In vitro K+ 100 μM
Flunarizine Marrannes et al.97 Rat In vivo Electrical 20–40 mg/kg/day ip.; per os 3 × 20 mg/kg/day = = =
Flunarizine Marrannes et al.97 Rat In vivo Electrical, KCl 10–20 mg/kg/day ip.; per os 20 mg/kg/day
Flunarizine Hansen and Lauritzen37 Rat In vivo Mechanical Per os 20 mg/kg/day = =
Flunarizine Wauquier et al.198 Rat In vivo Mechanical 40 mg/kg/day ip.
Flunarizine Li et al.199 Rat In vivo KCl 3 mg/kg ip.
Flunarizine Ashton et al.200 Guinea pig In vitro Electrical 40 mg/kg × 2 per os
Valproate Kaube and Goadsby179 Cat In vivo Mechanical 3.5–7 mg/kg/day iv. = = =
Valproate Peeters et al.102 Rat In vivo KCl 200 mg/kg ip. = =
Valproate Tepe et al.201 Rat In vivo KCl 75 mg/kg ip. = =
Valproate Bogdanov et al.185 Rat In vivo KCl 200 mg/kg/day ip.
Valproate Hoffmann et al.202 Rat In vivo Electrical, KCl 200 mg/kg/day ip./iv.
Valproate Ayata et al.50 Rat In vivo Electrical, KCl 25/50/100/200 mg/kg/day ip. = =
Sumatriptan Bradley et al.194 Cat In vivo KCl 0.3 mg/kg iv. = =
Sumatriptan Read et al.192 Rat In vivo KCl 0.3 mg/kg iv. =
Sumatriptan Moskowitz et al.203 Rat In vivo KCl 0.3 mg/kg iv. =
Sumatriptan Srienc et al.110 Rat retina In vitro Photothrombosis 3 mg/kg iv. =
Sumatriptan Knapp et al.204 Rat In vivo KCl 0.6 mg/kg ip.
Sumatriptan Wiedemann et al.205 Chicken In vitro KCl 1.5 mM
Dihydroergotamine Kaube and Goadsby179 Cat In vivo Mechanical 15 mg/kg iv. = =
Ergotamine Wiedemann et al.205 Chicken In vivo KCl 10–20 µM = =
Lamotrigine Bogdanov et al.185 Rat In vivo KCl 15 mg/kg/day ip. =
Riboflavin Bogdanov et al.185 Rat In vivo KCl 20 mg/kg/day ip. =
Propranolol Ayata et al.50 Rat In vivo Electrical, KCl 20 mg/kg/day ip. = = = = =
Propranolol Ayata et al.50 Rat In vivo Electrical, KCl 20 mg/kg/day ip. = = =
Propranolol Richter et al.206 Rat In vivo Mechanical Topical application of 250 – l µmol/L to 1 mmol/L = = =
Propranolol Peeters et al.102 Adult rat In vivo KCl Ip injection of 20 mg/kg ip. =
Propranolol Wiedemann et al.205 Chicken In vitro KCl 500 µmol
Methylsergide Ayata et al.50 Rat In vivo Electrical, KCl Ip injection of 0.1 and 1 mg/kg/day ip. = = = =
Methylsergide Wiedemann et al.205 Chicken In vitro KCl 100 µmol
Amitryptolin Ayata et al.50 Rat In vivo Electrical, KCl Ip injection of 10/20 mg/kg/day ip. = = = =
Clonidin Wiedemann et al.205 Chicken In vitro KCl 100–500 µM = = =
Lisuride Wiedemann et al.205 Chicken In vitro KCl 100–200 nM = = =
Iprazochrome Wiedemann et al.205 Chicken In vitro KCl 100–200 µM = = =
Isoprenalin Kaube et al.207 Cat In vivo Transection Topical application of 0.1/1% = =
Amylnitrite Kaube et al.207 Cat In vivo Transection Topical application of 0.05% = =

“↓” Means a reductive effect was observed after drug administration, “=” means no effect was noticed, and “↑” means that the tested parameter was increased by drug. Typical parameters under investigation are number, amplitude, propagation, threshold, duration, and frequency. Most substances exert an inhibitory effect on the number of SDs. Only few inhibit more than one variable, for instance, flunarizine, sumatriptan, and propranolol. Experimental settings and models are heterogeneous, comprising different animals (chicken, rat, and cat) and various forms of SD induction (KCl and electrical stimulation).